An observational study in Atrial Fibrillation, sponsored by Kardium Inc.. Completed at 1 site in Canada. Per ClinicalTrials.gov, last updated 2015-04-16.
Sponsored by Kardium Inc. · Observational
The purpose of this study is to gather information about the size and shape of patients' hearts in order to design a device.
Correct device design depends on getting good information about the shape and size of the different parts of the heart. Measurements from computed tomography images of hearts will be studied. By looking at measurements from a wide range of patients, an understanding of the differences in the size and shape of the heart chambers will be gained.
3,870 studies on the registry are indexed under Atrial Fibrillation; 924 are open to participants now.
This study's enrollment of 96 is below the median of 300 across 1,363 observational studies indexed under Atrial Fibrillation.
Browse Atrial Fibrillation studies →Kardium Inc. is the lead sponsor of 10 studies on the registry; 4 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with atrial fibrillation who are deemed suitable for treatment of atrial fibrillation by catheter-based ablation.
Exclusion Criteria:
Patients with atrial fibrillation who have received a cardiac CT scan as part of normal care prior to catheter-based treatment of atrial fibrillation.
Other: There is no intervention that is a part of this study.
There is no intervention that is a part of this study. Imaging data is gathered as part of normal care.
LA size measurements
Time frame: 3 months
This study is completed, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kardium Inc.